Skip to main content
Log in

Society of abdominal radiology survey of practice patterns in using LI-RADS treatment response criteria in the evaluation of hepatocellular carcinoma post-locoregional treatment

  • Hepatobiliary
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

To examine national trends in the adoption and use of the LI-RADS Treatment Response Algorithm.

Methods

Members of the Society of Abdominal Radiology (SAR) Disease-Focused Panel (DFP) on LI-RADS Treatment Response (LR-TR) of hepatocellular carcinoma (HCC) developed a 15-question survey which was distributed to radiologists at academic and private practice institutions around the USA and Canada. The survey focused on HCC-related practice patterns as well as the adoption and use of the LR-TR algorithm.

Results

Of 122 surveys distributed, a total of 76 radiologists responded (62%). Responders were predominantly from academic centers (85%). Nearly all (96%) participate in multidisciplinary hepatic tumor boards and most (67%) have an active liver transplant program. All responders’ institutions perform locoregional therapy for HCC, including radiation-based therapy (TARE and SBRT). There was a preference for use of MRI over CT for follow-up after locoregional therapy. All responders were aware of the LR-TR algorithm and nearly all (92%) used the system in routine practice. Radiologists expressed a need for more visual aids related to the LR-TR system. Multiple respondents requested additional clarity within the LR-TR algorithm regarding the evolution of post-treatment radiation changes over time.

Conclusion

Most survey participants use the LR-TR algorithm after locoregional therapy for HCC. Future iterations of the algorithm may benefit from increased clarity regarding response after radiation-based therapies. Educational materials should include more visual aids to improve reader understanding.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kampalath, R., Tran-Harding, K., Do, R. K. G., Mendiratta-Lala, M., & Yaghmai, V. (2021). Evaluation of hepatocellular carcinoma treatment response after Locoregional therapy. Magnetic Resonance Imaging Clinics of North America, 29(3), 389–403. https://doi.org/https://doi.org/10.1016/j.mric.2021.05.013

    Article  PubMed  Google Scholar 

  2. Ganesan, P., & Kulik, L. M. (2023). Hepatocellular carcinoma. Clinics in Liver Disease, 27(1), 85–102. https://doi.org/https://doi.org/10.1016/j.cld.2022.08.004

    Article  PubMed  Google Scholar 

  3. Li-RADS® CT/MRI. American College of Radiology. Retrieved March 13, 2023, from https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS/LI-RADS-CT-MRI-v2018

  4. Shropshire, E. L., Chaudhry, M., Miller, C. M., Allen, B. C., Bozdogan, E., Cardona, D. M., King, L. Y., Janas, G. L., Do, R. K., Kim, C. Y., Ronald, J., & Bashir, M. R. (2019). Li-Rads Treatment Response Algorithm: Performance and diagnostic accuracy. Radiology, 292(1), 226–234. https://doi.org/https://doi.org/10.1148/radiol.2019182135

    Article  PubMed  Google Scholar 

  5. Zhang, Y., Wang, J., Li, H., Zheng, T., Jiang, H., Li, M., & Song, B. (2020). Performance of li-rads version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single hepatocellular carcinoma after radiofrequency ablation. Annals of Translational Medicine, 8(6), 388–388. https://doi.org/10.21037/atm.2020.03.120

  6. Cools, K. S., Moon, A. M., Burke, L. M., McGinty, K. A., Strassle, P. D., & Gerber, D. A. (2019). Validation of the liver imaging reporting and Data System Treatment Response Criteria after thermal ablation for hepatocellular carcinoma. Liver Transplantation, 26(2), 203–214. https://doi.org/https://doi.org/10.1002/lt.25673

    Article  PubMed  PubMed Central  Google Scholar 

  7. Chaudhry, M., McGinty, K. A., Mervak, B., Lerebours, R., Li, C., Shropshire, E., Ronald, J., Commander, L., Hertel, J., Luo, S., Bashir, M. R., & Burke, L. M. (2020). The Li-rads version 2018 MRI treatment response algorithm: Evaluation of ablated hepatocellular carcinoma. Radiology, 294(2), 320–326. https://doi.org/https://doi.org/10.1148/radiol.2019191581

    Article  PubMed  Google Scholar 

  8. Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research Electronic Data Capture (redcap)—a metadata-driven methodology and workflow process for providing Translational Research Informatics Support. Journal of Biomedical Informatics, 42(2), 377–381. https://doi.org/https://doi.org/10.1016/j.jbi.2008.08.010

    Article  PubMed  Google Scholar 

  9. Harris, P. A., Taylor, R., Minor, B. L., Elliott, V., Fernandez, M., O'Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J., & Duda, S. N. (2019). The redcap consortium: Building an international community of Software Platform Partners. Journal of Biomedical Informatics, 95, 103208. https://doi.org/https://doi.org/10.1016/j.jbi.2019.103208

    Article  PubMed  PubMed Central  Google Scholar 

  10. Alenazi, A. O., Elsayes, K. M., Marks, R. M., Yacoub, J. H., Hecht, E. M., Chernyak, V., Krishna, S., Surabhi, V., Lee, J. T., Ash, R., Cruite, I., & Kielar, A. Z. (2020). Clinicians and surgeon survey regarding current and future versions of CT/MRI Li-rads. Abdominal Radiology, 45(8), 2603–2611. https://doi.org/https://doi.org/10.1007/s00261-020-02544-0

    Article  PubMed  Google Scholar 

  11. Mendiratta-Lala, M., Masch, W., Shankar, P. R., Hartman, H. E., Davenport, M. S., Schipper, M. J., Maurino, C., Cuneo, K. C., Lawrence, T. S., & Owen, D. (2019). Magnetic Resonance Imaging Evaluation of hepatocellular carcinoma treated with stereotactic body radiation therapy: Long term imaging follow-up. International Journal of Radiation Oncology*Biology*Physics, 103(1), 169–179. https://doi.org/https://doi.org/10.1016/j.ijrobp.2018.09.004

    Article  PubMed  Google Scholar 

  12. Oldrini, G., Huertas, A., Renard-Oldrini, S., Taste-George, H., Vogin, G., Laurent, V., Salleron, J., & Henrot, P. (2017). Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma. PLOS ONE, 12(4). https://doi.org/10.1371/journal.pone.0176118

Download references

Acknowledgements

The authors would like to thank Markeela Lipscomb, clinical research coordinator, without whom this survey would not have been possible.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rony Kampalath.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kampalath, R., Mendiratta-Lala, M., Lewis, S. et al. Society of abdominal radiology survey of practice patterns in using LI-RADS treatment response criteria in the evaluation of hepatocellular carcinoma post-locoregional treatment. Abdom Radiol 48, 3401–3407 (2023). https://doi.org/10.1007/s00261-023-04022-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-023-04022-9

Keywords

Navigation